METTL3 aggravates pulmonary inflammation in bronchopulmonary dysplasia by mediating the m6A modification of ATG8, suppressing its expression, disrupting the GSDMD interaction, inhibiting autophagy, and inducing pyroptosis (30). Here, METTL3 is linked to bronchopulmonary dysplasia.